Browse studies

Find your next paid study

27,384 recruiting studies available now

Newest first Highest paying

Phase 1

A Phase 1 Open-Label, Single Dose Study to Evaluate the Pharmacokinetics of Gepotidacin in Healthy Lactating Women

This study aims to evaluate the pharmacokinetic of gepotidacin in fed healthy lactating women.

Urinary Tract Infections

Estimated

~$500 – $11,250

Actual pay is set by the research site.

GlaxoSmithKlineNCT07645235

Phase 4

A Randomized Controlled Trial: Alternative Post Procedural Analgesia With NSAIDs vs Opioids in Percutaneous Needle Tenotomy of Elbow

This study is a double-blind, randomized controlled trial comparing the effectiveness of oral acetaminophen, diclofenac, and tramadol in reducing the consumpti…

Elbow PainChronic Pain

Estimated

~$25 – $1,000

Actual pay is set by the research site.

The Cleveland ClinicNCT06373978

Phase 2

ENERGIZE: Engagement With a Nurturing Exercise Routine for Greater Improvement in Zest and Energy on Enhertu: A Single-Center Pilot Study

The goal of this study is to test the efficacy of using a 12-week, home-based, unsupervised aerobic and resistance training exercise program for changes in can…

Metastatic Breast Cancer

Estimated

~$75 – $2,000

Actual pay is set by the research site.

University of UtahNCT07203378

Phase 2

A Phase 2, Open-Label, Multicenter Study of Arlocabtagene Autoleucel (BMS-986393), a GPRC5D-directed CAR T Cell Therapy in Adult Participants With Relapsed or Refractory Multiple Myeloma (QUINTESSENTIAL)

The purpose of this study is to evaluate the effectiveness and safety of Arlocabtagene Autoleucel (BMS-986393) in participants with relapsed or refractory mult…

Multiple Myeloma

Estimated

~$75 – $2,800

Actual pay is set by the research site.

Juno Therapeutics, Inc., a Bristol-Myers Squibb CompanyNCT06297226

Phase 1

A Phase I Study of DS-8201a in Combination With Olaparib in HER2-Expressing Malignancies

This phase I trial identifies the side effects and best dose of DS-8201a and olaparib in treating patients with HER2-expressing cancers that have spread to oth…

Metastatic Malignant Solid NeoplasmPlatinum-Resistant Ovarian High Grade Serous AdenocarcinomaUnresectable Malignant Solid Neoplasm

Estimated

~$150 – $2,700

Actual pay is set by the research site.

National Cancer Institute (NCI)NCT04585958

Phase 1

Evaluation of the Distribution of CM500 in Healthy Volunteers and Patients With Cancer

The objective of this study is to assess two novel positron emission tomography (PET) radiotracers, \[64Cu\]CM500 and \[68Ga\]CM500, for Positron Emission Tomo…

Bladder CancerGliomaGlioblastoma (GBM)+13 more

Estimated

~$500 – $10,500

Actual pay is set by the research site.

Lumina Pharmaceuticals IncNCT07781852

Phase 1

Phase I Randomized, Double-blind Study to Evaluate Feasibility, Safety, and Clinical Responses of Implanting Autologous Peripheral Nerve Tissue Into the Nucleus Basalis of Meynert or Substantia Nigra for Non-motor or Motor Symptoms in Patients With Parkinson's Disease Undergoing DBS Surgery

The investigators propose a Phase I single surgical-center, double-blinded randomized parallel clinical trial involving bilateral autologous peripheral nerve t…

Parkinson's Disease

Estimated

~$150 – $4,500

Actual pay is set by the research site.

Craig van Horne, MD, PhDNCT06683378

Phase 4

A Randomized Control Trial for Opioid Use After Laparoscopic Salpingectomy

The purpose of this study is to evaluate patient-reported post-operative pain scores following minimally invasive tubal sterilization procedures to determine i…

Opioid UsePost-operative PainSterility, Female

Estimated

~$25 – $1,000

Actual pay is set by the research site.

Johns Hopkins UniversityNCT06434233

Boehringer Laboratories Organ Retractor Device Study

This study aims to assess the safety and efficacy of an organ retraction device. The study is low risk as it is only being used in patients already undergoing …

Liver Retraction During Bariatric Surgery

Estimated

~$10 – $1,050

Actual pay is set by the research site.

Boehringer Labs LLCNCT06754514

Observational

Threat Interpretation Bias as Cognitive Marker and Treatment Target in Pediatric Anxiety: R33 Phase

Anxiety is chronic, debilitating, and the most common mental health problem across development, costing the U.S. over $42 billion annually. This phased innovat…

Anxiety Disorders

Estimated

~$10 – $750

Actual pay is set by the research site.

University of DenverNCT07818876

Observational

Virtual Group Resilient Living Program For Patients Living With Advanced Cancer

This study is a prospective, minimal risk, non-randomized, single-arm study to determine feasibility and assess effectiveness of a Virtual Group Resilient Livi…

Advanced Cancer

Estimated

~$10 – $750

Actual pay is set by the research site.

Mayo ClinicNCT07659158

Observational

Safety and Feasibility of Robotic Single-port (SP) Nipple Sparing Mastectomy: A Single Institution, Single Arm Pilot Trial

This is a single arm, single-center, prospective clinical trial designed to track the peri, post-operative and oncologic outcomes when utilizing the da-Vinci s…

Breast CancerHigh Risk of Breast Cancer

Estimated

~$10 – $1,125

Actual pay is set by the research site.

Deborah Farr, MDNCT05245812